Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.32 - $0.8 $1,728 - $4,320
-5,400 Reduced 84.38%
1,000 $0
Q1 2024

May 15, 2024

SELL
$0.81 - $1.45 $54,999 - $98,455
-67,900 Reduced 91.39%
6,400 $5,000
Q4 2023

Feb 14, 2024

BUY
$0.94 - $1.57 $4,982 - $8,321
5,300 Added 7.68%
74,300 $110,000
Q3 2023

Nov 14, 2023

SELL
$1.14 - $2.45 $3,875 - $8,330
-3,400 Reduced 4.7%
69,000 $80,000
Q2 2023

Aug 14, 2023

SELL
$1.99 - $2.65 $41,790 - $55,650
-21,000 Reduced 22.48%
72,400 $152,000
Q1 2023

May 15, 2023

SELL
$2.24 - $4.14 $52,192 - $96,461
-23,300 Reduced 19.97%
93,400 $220,000
Q4 2022

Feb 14, 2023

SELL
$2.79 - $4.17 $39,339 - $58,797
-14,100 Reduced 10.78%
116,700 $330,000
Q3 2022

Nov 14, 2022

SELL
$3.54 - $5.3 $133,812 - $200,340
-37,800 Reduced 22.42%
130,800 $470,000

Others Institutions Holding AMWL

About American Well Corp


  • Ticker AMWL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 240,622,000
  • Market Cap $2.28B
  • Description
  • American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nu...
More about AMWL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.